Detection of Carbapenemases in Clinical Enterobacteriaceae Isolates Using the VITEK AST-N202 Card
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Background: The rapid and accurate detection of carbapenemase-producing Enterobacteriaceae (CPE) in clinical microbiology laboratories is essential for the treatment and control of infections caused by these microorganisms. This study was performed to evaluate the ability of the VITEK AST-N202 card to detect CPE isolates. Materials and Methods: A total of 43 (Klebsiella pneumoniae, n = 37; Escherichia coli, n = 3; and Enterobacter cloacae, n = 3) CPE isolates and 79 carbapenemase-non-producing Enterobacteriaceae (CNE) isolates were included in this study. The CPE isolates harbored KPC-2 (n = 11), KPC-3 (n = 20), GES-5 (n = 5), VIM-2 (n = 2), IMP-1 (n = 1), NDM-1 (n = 2), or OXA-232 (n = 2). Of the 79 CNE isolates, eight K. pneumoniae isolates were resistant to ertapenem, imipenem, and meropenem, while the remaining 71 isolates were susceptible to the carbapenems. Antimicrobial susceptibilities were tested using the VITEK AST-N202 card, and the results were interpreted as positive when the isolates showed resistant or intermediate results. Modified-Hodge tests (MHTs) were performed using ertapenem or meropenem disks for the screening of carbapenemase production. Polymerase chain reaction (PCR) and direct sequencing were used to identify β-lactamase genes. Results: Sensitivity of MHT with ertapenem and meropenem disks for the detection of carbapenemase was 81.4% (35/43) and 81.4% (35/43), respectively, and a combination with both antibiotic disks increased the sensitivity to 88.4% (38/43). Specificity of the MHT was 100% (79/79) for the CNE isolates. Sensitivity of ertapenem, imipenem, and meropenem as assessed by the VITEK AST-N202 card was 100% (43/43), 93% (40/43), and 95.3% (41/43), respectively. Specificity (89.8%, 71/79) of the test with each carbapenem was improved to 100% (71/71) when eight carbapenem-resistant CNE isolates were excluded from the testing. Conclusion: The VITEK AST-N202 card showed high sensitivity for the detection of carbapenemases in Enterobacteriaceae strains. PCR and sequencing experiments for the detection of carbapenemases are recommended when clinical Enterobacteriaceae isolates show non-susceptibility to carbapenems.
Abstract
Background: The rapid and accurate detection of carbapenemase-producing Enterobacteriaceae (CPE) in clinical microbiology laboratories is essential for the treatment and control of infections caused by these microorganisms. This study was performed to evaluate the ability of the VITEK AST-N202 card to detect CPE isolates. Materials and Methods: A total of 43 (Klebsiella pneumoniae, n = 37; Escherichia coli, n = 3; and Enterobacter cloacae, n = 3) CPE isolates and 79 carbapenemase-non-producing Enterobacteriaceae (CNE) isolates were included in this study. The CPE isolates harbored KPC-2 (n = 11), KPC-3 (n = 20), GES-5 (n = 5), VIM-2 (n = 2), IMP-1 (n = 1), NDM-1 (n = 2), or OXA-232 (n = 2). Of the 79 CNE isolates, eight K. pneumoniae isolates were resistant to ertapenem, imipenem, and meropenem, while the remaining 71 isolates were susceptible to the carbapenems. Antimicrobial susceptibilities were tested using the VITEK AST-N202 card, and the results were interpreted as positive when the isolates showed resistant or intermediate results. Modified-Hodge tests (MHTs) were performed using ertapenem or meropenem disks for the screening of carbapenemase production. Polymerase chain reaction (PCR) and direct sequencing were used to identify β-lactamase genes. Results: Sensitivity of MHT with ertapenem and meropenem disks for the detection of carbapenemase was 81.4% (35/43) and 81.4% (35/43), respectively, and a combination with both antibiotic disks increased the sensitivity to 88.4% (38/43). Specificity of the MHT was 100% (79/79) for the CNE isolates. Sensitivity of ertapenem, imipenem, and meropenem as assessed by the VITEK AST-N202 card was 100% (43/43), 93% (40/43), and 95.3% (41/43), respectively. Specificity (89.8%, 71/79) of the test with each carbapenem was improved to 100% (71/71) when eight carbapenem-resistant CNE isolates were excluded from the testing. Conclusion: The VITEK AST-N202 card showed high sensitivity for the detection of carbapenemases in Enterobacteriaceae strains. PCR and sequencing experiments for the detection of carbapenemases are recommended when clinical Enterobacteriaceae isolates show non-susceptibility to carbapenems.
참고문헌 (26)
- Bergogne-Bérézin E, "Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features", Clin Microbiol Rev, 9, pp.148~165 (1996)
- Gehrlein M, "Imipenem resistance in Acinetobacter baumannii is due to altered penicillin binding proteins", Chemotherapy, 37, pp.405~412 (1991)
- Urban C, "Interactions of sulbactam, clavulanic acid and tazobactam with penicillin binding proteins of imipenem-resistant and susceptibile Acinetobacter baumannii", FEMS Microbiol Lett, 125, pp.193~197 (1995)
- Clark RB, "Imipenem resistance among Acinetobacter baumannii association with reduced expression of a 33-36kDa outer membrane protein", J Antimicrob Chemother, 38, pp.245~251 (1996)
- Walsh TR, "Emerging carbapenemase: a global perspective", Int J Antimicrob Agents, 36(Suppl 3), pp.S8~S14 (2010)
- Nordmann P, "Global spread of carbapenemase-producing Enterobacteriaceae", Emerg Infect Dis, 17, pp.1791~1798 (2011)
- Carrër A, "Use of ChromID extended-spectrum β-lactamase medium for detecting carbapenemase-producing Enterobacteriaceae", J Clin Microbiol, 48, pp.1913~1914 (2010)
- Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing: twenty-three informational supplement (M100-S23)", CLSI, ~ (2013)
- Bae IK, "Interspecies dissemination of the bla gene encoding PER-1 extended-spectrum β-lactamase", Antimicrob Agents Chemother, 55, pp.1305~1307 (2011)
- Tam VH, "Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa", Antimicrob Agents Chemother, 54, pp.1160~1164 (2010)
- 박광옥, "OXA-23 혹은 IMP-1 β-Lactamase 생성 Acinetobacter baumannii에 의한 감염의 분자 역학", Annals of Clinical Microbiology, 8(2), pp.121~129 (2005), 대한임상미생물학회
- 배일권, "CTX-M-12, PER-1 및 OXA-30 β-Lactamase 생성 Klebsiella pneumoniae의 출현", Annals of Clinical Microbiology, 9(2), pp.102~109 (2006), 대한임상미생물학회
- Rhee JY, "KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea.", Antimicrob Agents Chemother, 54, pp.2278~2279 (2010)
- 노경호, "Isolation of a Klebsiella pneumoniae Isolate of Sequence Type 258 Producing KPC-2 Carbapenemase in Korea", Annals of Laboratory Medicine, 31(4), pp.298~301 (2011), 대한진단검사의학회
- Yoo JS, "Detection of clonal KPC-2-producing Klebsiella pneumoniae ST258 in Korea during nationwide surveillance in 2011.", J Med Microbiol, 62, pp.1338~1342 (2013)
- Hong SK, "First outbreak of KPC-2-producing Klebsiella pneumoniae sequence type 258 in a hospital in South Korea", J Clin Microbiol, 51, pp.3877~3879 (2013)
- Lee Y, "Clonality and resistome analysis of KPC-producing Klebsiella pneumoniae strain isolated in Korea using whole genome sequencing", Biomed Res Int, 2014, pp.352862~ (2014)
- Ryoo NH, "Dissemination of SHV-12 and CTX-M-type extended-spectrum β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea", J Antimicrob Chemother, 56, pp.698~702 (2005)
- Jeong SH, "First outbreak of Klebsiella pneumoniae clinical isolates producing GES-5 and SHV-12 extended-spectrum β-lactamases in Korea", Antimicrob Agents Chemother, 49, pp.4809~4810 (2005)
- Kim J, "Emergence of Escherichia coli sequence type ST131 carrying both the blaGES-5 and blaCTX-M-15 genes", Antimicrob Agents Chemother, 55, pp.2974~2975 (2011)
- Yum JH, "A new integron carrying VIM-2 metallo-β-lactamase gene cassette in a Serratia marcescens isolate", Diagn Microbiol Infect Dis, 42, pp.217~219 (2002)
- Jeong SH, "Characterization of a new integron containing VIM-2, a metallo-β-lactamase gene cassette, in a clinical isolate of Enterobacter cloacae", J Antimicrob Chemother, 51, pp.397~400 (2003)
- Lee Y, "Molecualr mechanisms of carbapenem resistance in Enterobacter cloacae clinical isolates from Korea and clinical outcome", Ann Clin Lab Sci, 42, pp.281~286 (2012)
- Kim MN, "Nosocomial clustering of NDM-1-producing Klebsiella pneumoniae sequence type 340 strains in four patients at a South Korean tertiary care hospital", J Clin Microbiol, 50, pp.1433~1436 (2012)
- Jeong SH, "Clonal and horizontal spread of the blaOXA-232 gene among Enterobacteriaceae in a Korean hospital", Diagn Microbiol Infect Dis, 82, pp.70~72 (2015)
- Yoo JS, "Nosocomial transmission of NDM-1-producing Escherichia coli ST101 in a Korean Hospital.", J Antimicrob Chemother, 68, pp.2170~2172 (2013)